Positive Phase 1b Data of Parkinson’s Treatment Reported by Prothena
Prothena‘s potentially disease-modifying treatment for Parkinson’s disease, PRX002, met the primary objective in a Phase 1b multiple ascending dose…
Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Prothena‘s potentially disease-modifying treatment for Parkinson’s disease, PRX002, met the primary objective in a Phase 1b multiple ascending dose…
Intec Pharma recently announced that the protocol for the global Phase 3 Accordance clinical trial (NCT02605434) has been…
The Parkinson’s Disease Foundation (PDF) is marking this year’s National Family Caregivers Month by offering a set of free…
A new study showed that treadmill training with a virtual reality component reduced fall rates compared to treadmill training alone in a…
Intec Pharma has been granted a Chinese patent  covering the company’s Accordion Pill, an experimental technology platform to allow for…
A large genome-wide study discovered a strong association between essential tremor, commonly misdiagnosed as Parkinson’s disease, and a…
New research by the Leibniz-Institut für Molekulare Pharmakologie (FMP) aims to make possible the early detection of Parkinson’s disease (PD)…
A biomedical engineering professor from the University of Rhode Island (URI) is advancing the field of smart textiles to…
The Michael J. Fox Foundation (MJFF) and Nike have so far raised $6.75 million for Parkinson’s disease research though…
Researchers at the University of Alabama at Birmingham (UAB)Â were awarded a five-year $7.3 million grant from the National Institutes…
Get regular updates to your inbox.